In a regional milestone for minimally invasive thoracic surgery, Dr. Weijiang Huang and his team at Xiaogan Central Hospital successfully performed Central China’s first single-port robotic resection of a large anterior mediastinal tumor. The 44-year-old patient presented with chest tightness and was diagnosed with an 8 cm mass closely adherent to the heart—making traditional open surgery highly invasive and risky.
Leveraging the SHURUI® single-port surgical system, the team accessed the tumor via a right thoracic approach, using flexible snake-like instruments and high-definition 3D vision for precise dissection and reduced surgical trauma. The procedure was completed in just one hour with a sub-3cm incision. The patient began recovery rapidly, resuming liquid intake the same night and walking the next day.
This breakthrough marks a significant advancement for thoracic surgery in Central China, bringing world-class precision and ultra-minimally invasive care closer to home.
Important Notes
The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.
Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other
trademarks and may not be used without permission.
